Procyon Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.62M Sell
50,447
-1,274
-2% -$111K 0.2% 115
2026
Q1
$4.41M Buy
51,721
+11,277
+28% +$1.01M 0.22% 110
2025
Q4
$3.2M Buy
40,444
+23,260
+135% +$1.82M 0.16% 127
2025
Q3
$1.37M Buy
17,184
+5,603
+48% +$478K 0.08% 195
2025
Q2
$1.05M Sell
11,581
-1,985
-15% -$181K 0.1% 185
2025
Q1
$1.27M Buy
13,566
+9,403
+226% +$842K 0.08% 233
2024
Q4
$378K Buy
4,163
+42
+1% +$4.01K 0.02% 390
2024
Q3
$428K Buy
4,121
+7
+0.2% +$713 0.03% 377
2024
Q2
$399K Buy
4,114
+84
+2% +$7.75K 0.03% 355
2024
Q1
$363K Buy
4,030
+18
+0.4% +$1.52K 0.03% 383
2023
Q4
$320K Buy
4,012
+1,085
+37% +$81.6K 0.03% 403
2023
Q3
$208K Sell
2,927
-221
-7% -$16.5K 0.02% 450
2023
Q2
$243K Sell
3,148
-53
-2% -$4.1K 0.03% 397
2023
Q1
$241K Sell
3,201
-101
-3% -$7.51K 0.04% 338
2022
Q4
$260K Buy
+3,302
New +$248K 0.05% 316
2022
Q1
Sell
-2,477
Closed -$211K 341
2021
Q4
$211K Buy
+2,477
New +$193K 0.05% 309
2020
Q3
Sell
-247
Closed -$18K 355
2020
Q2
$18K Hold
247
0.01% 554
2020
Q1
$16K Hold
247
0.01% 518
2019
Q4
$17K Buy
+247
New +$16.8K 0.01% 524

Other funds holding CL

Procyon Advisors's CL Position: Q2 2026 in Review

Procyon Advisors reduced its Colgate-Palmolive (CL) stake by 2.5% in Q2 2026, selling an estimated $111K and leaving 50,447 shares worth $4.62M. The position accounts for 0.2% of the portfolio, ranked #115.

Procyon Advisors first reported a position in CL in Q4 2019 and has held it in 19 quarters since. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Procyon Advisors held 50,447 shares of Colgate-Palmolive worth $4.62M as of Q2 2026.
  • Procyon Advisors sold 1,274 Colgate-Palmolive shares in Q2 2026, an estimated $111K.
  • Colgate-Palmolive made up 0.2% of Procyon Advisors's portfolio in Q2 2026, its #115 holding.
  • Procyon Advisors first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 19 quarters since.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Procyon Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.